Modern methods aimed at glycemia management in patients with diabetes mellitus
DOI: 10.32364/2587-6821-2023-7-9-6
N.A. Chernikova1,2, M.A. Grigorieva1
1Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
2Central Clinical Hospital of Civil Aviation, Moscow, Russian Federation
Given the steady increase in the number of patients with diabetes mellitus, the need for sufficient and high-quality glucose monitoring forces researchers worldwide to create and study more and more new methods of managing blood sugar. Currently, continuous glucose monitoring demonstrates the best results. However, the use of modern technologies is not always possible in clinical practice. One of the currently discussed methods is the structured 7-point blood glucose monitoring. Such a self-care option contributes to the greater adherence of patients to treatment, improvement of their life quality, and risk reduction of diabetes acute complications. This article presents an overview of foreign studies devoted to assessing the possibilities of the structured 7-point blood glucose monitoring in practice. We also presented our own data demonstrating the benefits of using glucose meters with a mobile application as part of a modern approach to 7-point blood glucose monitoring for 14 days. It was aimed at effectively reducing the glycated hemoglobin level in patients with type 1 and type 2 diabetes mellitus.
Keywords: diabetes mellitus, glucose monitoring, hypoglycemia, hyperglycemia, acute complications of diabetes mellitus, mobile application.
For citation: Chernikova N.A., Grigorieva M.A. Modern methods aimed at glycemia management in patients with diabetes mellitus. Russian Medical Inquiry. 2023;7(9):592–597 (in Russ.). DOI: 10.32364/2587-6821-2023-7-9-6.
About the authors:
Natal'ya A. Chernikova — C. Sc. (Med.), associate professor of the Department of Endocrinology, Russian Medical Academy of Continuous Professional Education; 2/1, Barrikadnaya str., Moscow, 125993, Russian Federation; endocrinologist, Central Clinical Hospital of Civil Aviation; 7, Ivan'kovskoe road, Moscow, 125367, Russian Federation; ORCID iD 0000-0002-0562-8396.
Maria A. Grigorieva — endocrinologist, Russian Medical Academy of Continuous Professional Education; 2/1, Barrikadnaya str., Moscow, 125993, Russian Federation.
Contact information: Natal'ya A. Chernikova, e-mail: nachendoc@yandex.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 21.08.2023.
Revised 13.09.2023.
Accepted 29.09.2023.
2. Черникова Н.А. Эволюция непрерывного мониторирования глюкозы в современных клинических рекомендациях для пациентов с сахарным диабетом. Эндокринология: новости, мнения, обучение. 2020;9(4):59–65. DOI: 10.33029/2304-9529-2020-9-4-59-65. [Chernikova N.A. Evolution of continuous glucose monitoring in existing clinical guidelines for patient with diabetes mellitus. Endocrinology: News, Opinions, Training. 2020;9(4):59–65 (in Russ.)]. DOI: 10.33029/2304-9529-2020-9-4-59-65.
3. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. DOI: 10.2337/dc20-S002.
4. Sieber J., Flacke F., Link M. et al. Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study. Diabetes Ther. 2017;8(5):1079–1085. DOI: 10.1007/s13300-017-0306-z.
5. Zelada H., Recklein C.L., McGill J.B. Short-term multifactorial intervention (STEMI): An approach using structured blood glucose monitoring (BGM) and conventional therapies in persons with diabetes. J Family Med Prim Care. 2023;12(7):1412–1416. DOI: 10.4103/jfmpc.jfmpc_2172_22.
6. McGill J.B., Cole T.G., Nowatzke W. et al.; U.S. trial of the GlycoMark assay. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care. 2004;27(8):1859–1865. DOI: 10.2337/diacare.27.8.1859. PMID: 15277408.
7. Parkin C.G., Davidson J.A. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500–508. DOI: 10.1177/193229680900300314.
8. Yang Y., Lee E.Y., Kim H.S. et al. Effect of a Mobile Phone-Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled Trial. JMIR MhealthUhealth. 2020;8(2):e16266. DOI: 10.2196/16266.
9. Анциферов М.Б., Демидов Н.А., Котешкова О.М. и др. Оценка вариабельности уровня гликемии на основе самоконтроля. Результаты пилотного проекта. Эндокринология: новости, мнения, обучение. 2021;10(2):26–31. DOI: 10.33029/2304-9529-2021-10-2-26-31. [Antsiferov M.B., Demidov N.A., Koteshkova O.M. et al. Assessment of the variability of glycemic levels based on self-control. Pilot project results. Endocrinology: News, Opinions, Training. 2021;10(2):26–31 (in Russ.)]. DOI: 10.33029/2304-9529-2021-10-2-26-31.
10. Bailey T.S., Wallace J.F., Pardo S. et al. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol. 2017;11(4):736–743. DOI: 10.1177/1932296816680829.
11. Bergenstal R.M., Beck R.W., Close K.L. et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care. 2018;41(11):2275–2280. DOI: 10.2337/dc18-1581.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
